Contact

Representative before the EPO

Employment test 201 - 500 employees
Company dna cabinet plasseraud
operating since 1906
Headquarter in Paris and 7 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Employment test 11 - 50 employees
Company dna cabinet ores
operating since 1972
930.73
Headquarter in Paris
active in Legal Services, IP Consulting, and Matchmaking and Trading

We have observed 41 EP applications Hélène Marthe Georgette Leblois-Préhaud has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12305565

MMP2 as a predictive biomarker of response to antiangiogenic therapy and survival after therapy in cancer patients

IPC classification:
G01N 33/574
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION PUBLISHED
EP12306120

PEPTIDE ANTAGONISTS OF THE VASOPRESSIN-2 RECEPTOR

IPC classification:
A61K 38/17, A61P 13/12, C07K 14/435
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12725512

AN ANTIOXIDANT COMPOSITION

IPC classification:
A61K 31/05, A61K 31/695, A61K 36/81, A61K 36/82, A61K 36/87
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12737420

METHOD FOR INCREASING THE EFFICIENCY OF DOUBLE-STRAND BREAK-INDUCED MUTAGENSSIS

IPC classification:
C12N 9/22, C12N 15/82
Applicant:
Cellectis SA
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Carole Sellin, Ernest Gutmann - Yves Plasseraud SAS (EGYP)
Agent:
Gevers & Orès
Status:
PATENT GRANTED
EP12735048

COMPOSITIONS FOR THE TREATMENT OF FRAGILE X SYNDROME

IPC classification:
A61K 31/404, A61P 25/00, A61P 25/28
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Centre Hospitalier Régional d'Orléans
Applicant:
University of Orléans (Université d'Orléans)
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP12778785

HIGH THROUGHPUT METHOD FOR ASSEMBLY AND CLONING POLYNUCLEOTIDES COMPRISING HIGHLY SIMILAR POLYNUCLEOTIDIC MODULES

IPC classification:
C12N 15/66, C12P 19/34
Applicant:
Cellectis SA
Agent:
Santarelli
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
The patent has been granted
EP12727439

COMBINATION OF ONCOLYTIC ADENOVIRUSES WITH HISTONE DEACETYLASE INHIBITORS

IPC classification:
A61K 35/76, C12N 7/00
Applicant:
Institut Gustave Roussy
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Plasseraud
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP12715261

NEW TALE-PROTEIN SCAFFOLDS AND USES THEREOF

IPC classification:
A61K 38/16, C12N 9/22, C12N 15/10
Applicant:
Cellectis SA
Agent:
Santarelli
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP10813011

SCREENING METHODS FOR IDENTIFYING PLASMODIUM PROTEASES INHIBITORS

IPC classification:
C12Q 1/37, G01N 33/569
Applicant:
Institut Pasteur
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP12784339

METHOD FOR TREATING SURFACES CONTAMINATED BY PRIONS

IPC classification:
A61L 2/18, C11D 3/395
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP13190312

Method for enhancing the cleavage activity of I-CreI derived meganucleases

IPC classification:
C12N 9/22
Applicant:
Cellectis SA
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12802513

METHODS FOR THE PROGNOSTIC AND/OR DIAGNOSTIC OF NEURODEGENERATIVE DISEASE, METHODS TO IDENTIFY CANDIDATE COMPOUNDS AND COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASE

IPC classification:
A01K 67/027, A61K 31/58, A61P 25/28, C07K 14/47, C12N 15/12, C12N 15/85, C12Q 1/00, G01N 33/48, G01N 33/53
Applicant:
Université Laval
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP12750124

CYSTAMINE ANALOGUES FOR THE TREATMENT OF PARKINSON'S DISEASE

IPC classification:
A61K 31/145, A61K 31/185, A61K 31/198, A61P 25/16
Applicant:
Université Laval
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Gevers & Orès
Status:
The patent has been granted
EP11807784

LAR PROTEIN-SPECIFIC LIGAND

IPC classification:
A61K 31/713, A61K 47/48, A61P 3/00, A61P 9/00, A61P 35/00, C12N 15/115, C12Q 1/68
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Plasseraud
Agent:
Gevers & Orès
Status:
The patent has been granted
EP14161697

Method for decontamination of animal products

IPC classification:
A23J 1/00, A23J 1/10, A23K 1/10
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
PATENT GRANTED
EP13305400

New uranium-chelating peptides derived from EF-hand calcium-binding motif useful for uranium biodetection and biodecontamination

IPC classification:
C07K 14/47, C07K 19/00
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305485

Methods to monitor consciousness

IPC classification:
A61B 5/00, A61B 5/0484
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305469

Methods to obtain a novel class of gram negative bacteria antibiotics which target an unknown cell division associated protein LOP1

IPC classification:
G01N 33/50, G01N 33/569
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Institut Pasteur
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13710036

IMPROVED CANCER TREATMENT BY IMMUNOTHERAPY WITH BCG OR ANTIGENICALLY RELATED NON-PATHOGENIC MYCOBACTERIA

IPC classification:
A61K 39/07
Applicant:
University Hospital Basel (Universitätsspital Basel)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Institut Pasteur
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12171941

Method for detecting and identifying enterohemorrhagic Escherichia coli

IPC classification:
C12Q 1/68
Agent:
Multiple attorneys, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13720022

ELECTRONIC NOSE OR TONGUE SENSORS

IPC classification:
G01N 33/00, G01N 33/543
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP13305964

Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies

IPC classification:
A01K 67/027, C07K 16/00, C12N 5/0735, C12N 5/16
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12305828

Vector for the selective silencing of a gene in astrocytes

IPC classification:
C12N 15/11, C12N 15/86
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Multiple attorneys, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11797269

METHOD FOR DETECTING AND QUANTIFYING MICROORGANISMS

IPC classification:
C12Q 1/04, C12Q 1/06, C12Q 1/18, G01N 33/543, G01N 33/569
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Université Joseph Fourier Grenoble
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Gevers & Orès
Status:
The patent has been granted
EP13720081

HB-EGF INHIBITOR DERIVED FROM THE R DOMAIN OF DIPHTHERIA TOXIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF THE HB-EGF/EGFR PATHWAY

IPC classification:
A61K 38/16, C07K 14/34, C12N 1/21, C12N 15/31, G01N 33/574
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Plasseraud
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP13724362

METHOD TO OVERCOME DNA CHEMICAL MODIFICATIONS SENSITIVITY OF ENGINEERED TALE DNA BINDING DOMAINS

IPC classification:
C12N 9/10, C12N 9/16, C12N 9/88, C12N 15/10
Applicant:
Cellectis SA
Agent:
Thierry Alain Caen, Santarelli
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP13306082

Computer-implemented method for classification of a picture

IPC classification:
G06T 7/00
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Lionel Vial, Cabinet Lionel Vial
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306125

Method of deconvolution of mixed molecular information in a complex sample to identify organism(s)

IPC classification:
G06F 19/14, G06F 19/18
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306198

USE OF ARPIN A NEW INHIBITOR OF THE ARP2/3 COMPLEX FOR THE DIAGNOSIS AND TREATMENT OF DISEASES

IPC classification:
A61K 38/17, A61P 25/00, C07K 14/47, G01N 33/50
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13735437

MMP2 AS A PREDICTIVE BIOMARKER OF RESPONSE TO ANTIANGIOGENIC THERAPY AND SURVIVAL AFTER THERAPY IN CANCER PATIENTS

IPC classification:
G01N 33/574
Applicant:
Assistance Publique Hôpitaux de Marseille
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13737378

STRESS-REGULATED PROKARYOTIC EXPRESSION CASSETTES

IPC classification:
A61K 39/09, C12N 15/74
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13735444

VECTOR FOR THE SELECTIVE SILENCING OF A GENE IN ASTROCYTES

IPC classification:
C12N 15/11, C12N 15/86
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Plasseraud
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP14193756

Panel for the detection and differentiation of renal cortical neoplasms

IPC classification:
C07H 21/04, C12Q 1/68
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306512

Peptide inhibitors of TEAD/YAP-TAZ interaction

IPC classification:
A61K 38/00, A61K 38/17, C07K 14/00, C07K 14/47, C07K 19/00
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13801742

PEPTIDE ANTAGONISTS OF THE VASOPRESSIN-2 RECEPTOR

IPC classification:
A61K 38/17, A61P 13/12, C07K 14/435
Applicant:
University of Regensburg (Universität Regensburg)
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Liège - Gembloux Agro-Bio Tech
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP14305174

A new non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against HIV infection

IPC classification:
A61K 39/02, A61P 31/18, C07K 16/12, G01N 33/48
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13799108

RECOMBINANT NOVIRHABDOVIRUS USABLE AS AN ANTIGEN VECTOR

IPC classification:
A61K 39/12, A61K 39/205, A61K 39/295, C12N 15/86
Applicant:
Institut National de la Recherche Agronomique (INRA)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP13828816

METHOD TO OBTAIN ANTIGEN-SPECIFIC HUMAN ANTIBODIES USING IN VITRO IMMUNISATION

IPC classification:
A61K 39/39
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Plasseraud
Agent:
Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP14305509

Enzyme-independent photon emission

IPC classification:
G01N 21/76, G01N 33/58
Applicant:
Institut Pasteur
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14704179

TEVI CHIMERIC ENDONUCLEASE AND THEIR PREFERENTIAL CLEAVAGE SITES

IPC classification:
C12N 9/22, C12N 15/82, C12N 15/90
Applicant:
Cellectis SA
Agent:
Santarelli
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP14718767

NEW URANIUM-CHELATING PEPTIDES DERIVED FROM EF-HAND CALCIUM-BINDING MOTIF USEFUL FOR URANIUM BIODETECTION AND BIODECONTAMINATION

IPC classification:
C07K 14/47, C07K 19/00
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Hélène Marthe Georgette Leblois-Préhaud, Cabinet Orès
Agent:
Gevers & Orès
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature